首页|期刊导航|生物医学研究杂志:英文版|Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides,anti-OX40,anti-PD1 antibodies,and aptamers
Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides,anti-OX40,anti-PD1 antibodies,and aptamers
Anastasia S.Proskurina Vera S.Ruzanova Genrikh S.Ritter Yaroslav R.Efremov Zakhar S.Mustafin Sergey A.Lashin Ekaterina A.Burakova Alesya A.Fokina Timofei S.Zatsepin Dmitry A.Stetsenko Olga Y.Leplina Alexandr A.Ostanin Elena R.Chernykh Sergey S.Bogachev
生物医学研究杂志:英文版2023,Vol.37Issue(3):P.194-212,19.
生物医学研究杂志:英文版2023,Vol.37Issue(3):P.194-212,19.DOI:10.7555/JBR.36.20220052
Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides,anti-OX40,anti-PD1 antibodies,and aptamers
摘要
关键词
immunogenicity/Krebs-2 carcinoma/Lewis carcinoma/Ehrlich carcinoma/A20 B cell lymphoma/mesyl phosphoramidate分类
医药卫生引用本文复制引用
Anastasia S.Proskurina,Vera S.Ruzanova,Genrikh S.Ritter,Yaroslav R.Efremov,Zakhar S.Mustafin,Sergey A.Lashin,Ekaterina A.Burakova,Alesya A.Fokina,Timofei S.Zatsepin,Dmitry A.Stetsenko,Olga Y.Leplina,Alexandr A.Ostanin,Elena R.Chernykh,Sergey S.Bogachev..Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides,anti-OX40,anti-PD1 antibodies,and aptamers[J].生物医学研究杂志:英文版,2023,37(3):P.194-212,19.基金项目
supported by the Russian Ministry of Science and High Education via the Institute of Cytology and Genetics (State Budget Project No.FWNR-2022-0016) (State Budget Project No.FWNR-2022-0016)
the Russian Foundation for Basic Research (Grant No.18-29-09045). (Grant No.18-29-09045)